Artelo biosciences reports first quarter 2023 financial results and provides business update

Cash on hand of $15.5m expected to support completion of the cares trial and operations into second half of 2024 cash on hand of $15.5m expected to support completion of the cares trial and operations into second half of 2024
ARTL Ratings Summary
ARTL Quant Ranking